1 ptomycetes proteins, the fungal protein is a surface active agent.

2                       Lung surfactant is the surface-active agent comprised of phospholipids and prot

3                     Two-dimensional films of surface-active agents-from phospholipids and proteins to

4      Therapeutic administration of non-ionic surface-active agents is known to facilitate early colla

5 hat modification of tooth permselectivity by surface-active agents may be a viable method of decreasi

6 erved when KSL was used in the presence of a surface-active agent, or after biofilms were mechanicall

7 t of a nontoxic, nonionic block co-polymeric surface active agent, poloxamer 188, on electroporation